Results 271 to 280 of about 564,228 (347)

Associations between Nugent‐bacterial vaginosis and preterm birth and other adverse pregnancy outcomes in rural northwestern Bangladesh

open access: yesInternational Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective Bacterial vaginosis, defined by Nugent score (Nugent‐BV), has been associated with preterm birth and other adverse pregnancy outcomes. However, few studies have longitudinally described the associations between Nugent‐BV and adverse pregnancy outcomes at varying times in pregnancy.
Daniel J. Erchick   +15 more
wiley   +1 more source

Post protocol residual thickness as a negative predictor for pharmacological treatment in early pregnancy loss

open access: yesInternational Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective To determine the rate of pharmacological treatment failure in early pregnancy loss, assess post‐treatment residua thickness as a predictor of retained products of conception (RPOC), identify a clinically relevant cutoff, and evaluate additional clinical and sonographic predictors. Methods This retrospective cohort study was conducted
Ravit Pertez‐Machluf   +7 more
wiley   +1 more source

Evaluation of Acute Exposure to Combustible and Novel Tobacco Products Using an In Vitro Human Airway Organ Tissue Equivalent Model

open access: yesJournal of Applied Toxicology, EarlyView.
ABSTRACT Despite the well‐known risks of tobacco use, tobacco exposure remains a major contributor to morbidity and mortality worldwide. Although cigarette use has declined, the popularity of novel tobacco products (NTPs), such as electronic cigarettes (ECs) and heated tobacco products (HTPs), has increased.
Timothy S. Leach   +8 more
wiley   +1 more source

Using generalized quantitative structure–property relationship (QSPR) models to predict host cell protein retention in ion‐exchange chromatography

open access: yesJournal of Chemical Technology &Biotechnology, EarlyView.
Abstract BACKGROUND Selecting an optimal chromatography resin during biopharmaceutical downstream process development is a great challenge. This is especially the case for recombinant subunit vaccines, where product properties vary greatly and recovery often involves cell lysis, which yields a complex mixture of different host cell materials. Host cell
Tim Neijenhuis   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy